Search results

ISSUE NO. 19 — Hallucinogens, Psychedelics, Entactogens: Challenges Associated With Schedule 1 Therapeutic Development

Sep 10, 2021

• Preclinical Research
• Clinical Trials
• Manufacturing and Analytical Services

ISSUE NO. 18 — Planning Your First-in-Human Trial

Aug 27, 2021

• Clinical Trials

ISSUE NO. 8 — Bioanalytical Challenges Encountered when Developing ADA Assays

Mar 1, 2019

• Bioanalysis

ISSUE NO. 6 — Hybrid Medicines and 505(b)(2) NDA Approval Pathways — Updated 2021

Dec 1, 2018

• Regulatory Affairs
• End-to-End Program

Scientific Publication

Case Study—Driving Simulator Assessment

Dec 6, 2024

• Clinical Trials

ISSUE NO. 42 — Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development

Nov 1, 2024

• End-to-End Program
• Preclinical Research
• Clinical Trials
• Bioanalysis

Blog

Inside The Altascientist Issue 40: Analytical Testing–Accurate and Complete Characterization of Your API to Maximize Bioavailability

Oct 7, 2024

• Manufacturing and Analytical Services